Kooijman Marjolein N, Jaddoe Vincent W V, Steegers Eric A P, Gaillard Romy
The Generation R Study Group, the Netherlands; Department of Pediatrics, the Netherlands.
Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Eur J Obstet Gynecol Reprod Biol. 2021 Feb;257:51-58. doi: 10.1016/j.ejogrb.2020.12.011. Epub 2020 Dec 10.
Maternal obesity and metabolic health affect pregnancy outcomes. We examined whether maternal metabolic profiles are associated with placental and fetal hemodynamics.
In a population-based prospective cohort study among 1175 women we examined the associations of an adverse maternal metabolic profile in early pregnancy with placental, fetal cerebral and cardiac hemodynamic development. We obtained maternal pre-pregnancy BMI by questionnaire and measured blood pressure, cholesterol, triglycerides and glucose concentrations at a median gestational age of 12.6 (95 % range 9.6-17.1) weeks. An adverse maternal metabolic profile was defined as ≥4 risk factors. Placental and fetal hemodynamics were measured by pulsed-wave-Doppler at a median gestational age of 30.3 (95 % range 28.8-32.3) weeks.
An adverse maternal metabolic profile was associated with a 0.29 Z-score higher (95 %CI 0.08-0.50) fetal cerebral middle artery pulsatility index (PI), but not with placental or fetal cardiac hemodynamic patterns. When the individual components of an adverse maternal metabolic profile were assessed, we observed that higher maternal total cholesterol and triglyceride concentrations were associated with a higher cerebral middle artery PI (Z-score, 0.09 (95 %CI 0.02-0.15), 0.09 (95 %CI 0.03-0.15) per Z-score increase). Higher total and HDL maternal cholesterol concentrations were also associated with a higher aorta ascendens peak systolic velocity (PSV) Z-score, 0.08 (95 %CI 0.01-0.14)), and a larger left cardiac output (Z-score, 0.08 (95 %CI 0.00-0.15), respectively).
An adverse maternal metabolic profile, especially higher cholesterol and triglycerides concentrations, are associated with increased fetal cerebral vascular resistance and larger fetal aorta ascendens diameter, PSV and left cardiac output, but not with placental vascular resistance indices. Further studies are needed to identify long-term consequences of the observed associations.
母亲肥胖和代谢健康会影响妊娠结局。我们研究了母亲的代谢状况是否与胎盘和胎儿血流动力学相关。
在一项基于人群的前瞻性队列研究中,我们对1175名女性进行了研究,探讨孕早期不良母亲代谢状况与胎盘、胎儿脑和心脏血流动力学发育之间的关联。我们通过问卷调查获取母亲孕前体重指数,并在孕12.6周(95%范围9.6 - 17.1周)的中位孕周测量血压、胆固醇、甘油三酯和血糖浓度。不良母亲代谢状况定义为≥4个风险因素。在孕30.3周(95%范围28.8 - 32.3周)的中位孕周,通过脉冲波多普勒测量胎盘和胎儿血流动力学。
不良母亲代谢状况与胎儿脑动脉中动脉搏动指数(PI)Z值高0.29相关(95%可信区间0.08 - 0.50),但与胎盘或胎儿心脏血流动力学模式无关。当评估不良母亲代谢状况的各个组成部分时,我们观察到母亲总胆固醇和甘油三酯浓度升高与脑动脉中动脉PI升高相关(Z值,每Z值增加0.09(95%可信区间0.02 - 0.15),0.09(95%可信区间0.03 - 0.15))。母亲总胆固醇和高密度脂蛋白胆固醇浓度升高也分别与升主动脉收缩期峰值速度(PSV)Z值升高0.08(95%可信区间0.01 - 0.14)和左心输出量增大(Z值,0.08(95%可信区间0.00 - 0.15))相关。
不良母亲代谢状况,尤其是较高的胆固醇和甘油三酯浓度,与胎儿脑血管阻力增加以及胎儿升主动脉直径增大、PSV和左心输出量增大相关,但与胎盘血管阻力指数无关。需要进一步研究来确定所观察到的关联的长期后果。